{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:31:48Z","timestamp":1787657508718,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health - National Eye Institute","award":["5R01EY015534"],"award-info":[{"award-number":["5R01EY015534"]}]},{"DOI":"10.13039\/100008569","name":"Oklahoma Center for the Advancement of Science and Technology","doi-asserted-by":"crossref","award":["HR12-068"],"award-info":[{"award-number":["HR12-068"]}],"id":[{"id":"10.13039\/100008569","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Histochem Cell Biol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00418-015-1347-x","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T09:44:58Z","timestamp":1436780698000},"page":"293-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"144","author":[{"given":"Amanda J.","family":"Brock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kasus-Jacobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreemathi","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle M.","family":"Adesina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Anne Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"issue":"4","key":"1347_CR1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/JAD-2008-13403","volume":"13","author":"BJ Balin","year":"2008","unstructured":"Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gerard HC, Hudson AP (2008) Chlamydophila pneumoniae and the etiology of late-onset Alzheimer\u2019s disease. J Alzheimers Dis 13(4):371\u2013380","journal-title":"J Alzheimers Dis"},{"key":"1347_CR2","doi-asserted-by":"crossref","unstructured":"Bu XL, Yao XQ, Jiao SS, Zeng F, Liu YH, Xiang Y, Liang CR, Wang QH, Wang X, Cao HY, Yi X, Deng B, Liu CH, Xu J, Zhang LL, Gao CY, Xu ZQ, Zhang M, Wang L, Tan XL, Xu X, Zhou HD Wang YJ (2014) A study on the association between infectious burden and Alzheimer\u2019s disease. Eur J Neurol.\u00a0doi: 10.1111\/ene.12477","DOI":"10.1111\/ene.12477"},{"issue":"9","key":"1347_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrn1495","volume":"5","author":"M Citron","year":"2004","unstructured":"Citron M (2004) Strategies for disease modification in Alzheimer\u2019s disease. Nat Rev Neurosci 5(9):677\u2013685","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"1347_CR4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","volume":"9","author":"M Citron","year":"2010","unstructured":"Citron M (2010) Alzheimer\u2019s disease: strategies for disease modification. Nat Rev Drug Discov 9(5):387\u2013398","journal-title":"Nat Rev Drug Discov"},{"issue":"36","key":"1347_CR5","doi-asserted-by":"crossref","first-page":"23004","DOI":"10.1074\/jbc.273.36.23004","volume":"273","author":"BJ Davies","year":"1998","unstructured":"Davies BJ, Pickard BS, Steel M, Morris RGM, Lathe R (1998) Serine proteases in rodent hippocampus. J Biol Chem 273(36):23004\u201323011","journal-title":"J Biol Chem"},{"issue":"2","key":"1347_CR6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00023.2009","volume":"90","author":"B Strooper De","year":"2010","unstructured":"De Strooper B (2010) Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev 90(2):465\u2013494","journal-title":"Physiol Rev"},{"issue":"3","key":"1347_CR7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1096\/fj.05-3956com","volume":"20","author":"DL Dickstein","year":"2006","unstructured":"Dickstein DL, Biron KE, Ujiie M, Pfeifer CG, Jeffries AR, Jefferies WA (2006) Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J 20(3):426\u2013433","journal-title":"FASEB J"},{"key":"1347_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","volume":"11","author":"D Doens","year":"2014","unstructured":"Doens D, Fernandez PL (2014) Microglia receptors and their implications in the response to amyloid beta for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation 11:48","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1347_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt118","volume":"4","author":"P Eikelenboom","year":"2012","unstructured":"Eikelenboom P, Hoozemans JJ, Veerhuis R, van Exel E, Rozemuller AJ, van Gool WA (2012) Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer\u2019s disease. Alzheimers Res Ther 4(3):15","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"1347_CR10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33(10):1500\u20131513","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 6","key":"1347_CR11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/brain\/119.6.2001","volume":"119","author":"NC Fox","year":"1996","unstructured":"Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, Rossor MN (1996) Presymptomatic hippocampal atrophy in Alzheimer\u2019s disease. A longitudinal MRI study. Brain 119(Pt 6):2001\u20132007","journal-title":"Brain"},{"issue":"10","key":"1347_CR12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm1001-1123","volume":"7","author":"N Gautam","year":"2001","unstructured":"Gautam N, Olofsson AM, Herwald H, Iversen LF, Lundgren-Akerlund E, Hedqvist P, Arfors KE, Flodgaard H, Lindbom L (2001) Heparin-binding protein (HBP\/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 7(10):1123\u20131127","journal-title":"Nat Med"},{"issue":"2","key":"1347_CR13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mvr.2003.12.007","volume":"67","author":"ML Gonzalez","year":"2004","unstructured":"Gonzalez ML, Ruan X, Kumar P, Grammas P, Pereira HA (2004) Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res 67(2):168\u2013181","journal-title":"Microvasc Res"},{"key":"1347_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-8-26","volume":"8","author":"P Grammas","year":"2011","unstructured":"Grammas P (2011) Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer\u2019s disease. J Neuroinflammation 8:26","journal-title":"J Neuroinflammation"},{"issue":"10","key":"1347_CR15","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1167\/iovs.13-12054","volume":"54","author":"GL Griffith","year":"2013","unstructured":"Griffith GL, Russell RA, Kasus-Jacobi A, Thavathiru E, Gonzalez ML, Logan S, Pereira HA (2013) CAP37 activation of PKC promotes human corneal epithelial cell chemotaxis. Invest Ophthalmol Vis Sci 54(10):6712\u20136723","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1347_CR16","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1167\/iovs.14-14461","volume":"55","author":"GL Griffith","year":"2014","unstructured":"Griffith GL, Kasus-Jacobi A, Lerner MR, Pereira HA (2014) Corneal wound healing, a newly identified function of CAP37, is mediated by protein kinase C delta (PKCdelta). Invest Ophthalmol Vis Sci 55(8):4886\u20134895","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1347_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nic.2011.11.003","volume":"22","author":"CR Harrington","year":"2012","unstructured":"Harrington CR (2012) The molecular pathology of Alzheimer\u2019s disease. Neuroimaging Clin N Am 22(1):11\u201322","journal-title":"Neuroimaging Clin N Am"},{"issue":"8","key":"1347_CR18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","volume":"117","author":"MT Heneka","year":"2010","unstructured":"Heneka MT, O\u2019Banion MK, Terwel D, Kummer MP (2010) Neuroinflammatory processes in Alzheimer\u2019s disease. J Neural Transm 117(8):919\u2013947","journal-title":"J Neural Transm"},{"issue":"1","key":"1347_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2010-1414","volume":"21","author":"K Hensley","year":"2010","unstructured":"Hensley K (2010) Neuroinflammation in Alzheimer\u2019s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis 21(1):1\u201314","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1347_CR20","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s00415-013-7047-3","volume":"260","author":"L Kaerst","year":"2013","unstructured":"Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I (2013) Cerebrospinal fluid biomarkers in Alzheimer\u2019s disease, vascular dementia and ischemic stroke patients: a critical analysis. J Neurol 260(11):2722\u20132727","journal-title":"J Neurol"},{"issue":"11","key":"1347_CR21","doi-asserted-by":"crossref","first-page":"e81654","DOI":"10.1371\/journal.pone.0081654","volume":"8","author":"E Kapaki","year":"2013","unstructured":"Kapaki E, Paraskevas GP, Emmanouilidou E, Vekrellis K (2013) The diagnostic value of CSF alpha- synuclein in the differential diagnosis of dementia with Lewy bodies versus normal subjects and patients with Alzheimer\u2019s disease. PLoS One 8(11):e81654","journal-title":"PLoS One"},{"issue":"2","key":"1347_CR22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"UA Khan","year":"2014","unstructured":"Khan UA, Liu L, Provenzano FA, Berman DE, Profaci CP, Sloan R, Mayeux R, Duff KE, Small SA (2014) Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nat Neurosci 17(2):304\u2013311","journal-title":"Nat Neurosci"},{"issue":"4","key":"1347_CR23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","volume":"62","author":"B Korkmaz","year":"2010","unstructured":"Korkmaz B, Horwitz MS, Jenne DE, Gauthier F (2010) Neutrophil elastase, proteinase 3 and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 62(4):726\u2013759","journal-title":"Pharmacol Rev"},{"issue":"3","key":"1347_CR24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0002-9440(10)64907-3","volume":"160","author":"TD Lee","year":"2002","unstructured":"Lee TD, Gonzalez ML, Kumar P, Chary-Reddy S, Grammas P, Pereira HA (2002) CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions. Am J Pathol 160(3):841\u2013848","journal-title":"Am J Pathol"},{"issue":"10","key":"1347_CR25","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nm1001-1105","volume":"7","author":"K Ley","year":"2001","unstructured":"Ley K (2001) Plugging the leaks. Nat Med 7(10):1105\u20131106","journal-title":"Nat Med"},{"issue":"7","key":"1347_CR26","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/605563","volume":"49","author":"A Linder","year":"2009","unstructured":"Linder A, Christensson B, Herwald H, Bjorck L, Akesson P (2009) Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis 49(7):1044\u20131050","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1347_CR27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/CCM.0b013e318206c396","volume":"39","author":"A Linder","year":"2011","unstructured":"Linder A, Akesson P, Brink M, Studahl M, Bjorck L, Christensson B (2011) Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Crit Care Med 39(4):812\u2013817","journal-title":"Crit Care Med"},{"key":"1347_CR28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-8-38","volume":"8","author":"F Marques","year":"2013","unstructured":"Marques F, Sousa JC, Sousa N, Palha JA (2013) Blood-brain-barriers in aging and in Alzheimer\u2019s disease. Mol Neurodegener 8:38","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1347_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","volume":"126","author":"PL McGeer","year":"2013","unstructured":"McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol 126(4):479\u2013497","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1347_CR30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/JAD-2008-13404","volume":"13","author":"J Miklossy","year":"2008","unstructured":"Miklossy J (2008) Chronic inflammation and amyloidogenesis in Alzheimer\u2019s disease\u2014role of Spirochetes. J Alzheimers Dis 13(4):381\u2013391","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1347_CR31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1471-4159.1992.tb11356.x","volume":"58","author":"K Nakajima","year":"1992","unstructured":"Nakajima K, Shimojo M, Hamanoue M, Ishiura S, Sugita H, Kohsaka S (1992) Identification of elastase as a secretory protease from cultured rat microglia. J Neurochem 58(4):1401\u20131408","journal-title":"J Neurochem"},{"issue":"6","key":"1347_CR32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/jlb.57.6.805","volume":"57","author":"HA Pereira","year":"1995","unstructured":"Pereira HA (1995) CAP37, a neutrophil-derived multifunctional inflammatory mediator. J Leukoc Biol 57(6):805\u2013812","journal-title":"J Leukoc Biol"},{"issue":"4","key":"1347_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/138920106777950771","volume":"7","author":"HA Pereira","year":"2006","unstructured":"Pereira HA (2006) Novel therapies based on cationic antimicrobial peptides. Curr Pharm Biotechnol 7(4):229\u2013234","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"1347_CR34","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1172\/JCI114593","volume":"85","author":"HA Pereira","year":"1990","unstructured":"Pereira HA, Shafer WM, Pohl J, Martin LE, Spitznagel JK (1990a) CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest 85(5):1468\u20131476","journal-title":"J Clin Invest"},{"issue":"3","key":"1347_CR35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0024-3205(90)90104-Y","volume":"46","author":"HA Pereira","year":"1990","unstructured":"Pereira HA, Spitznagel JK, Pohl J, Wilson DE, Morgan J, Palings I, Larrick JW (1990b) CAP 37, a 37 kD human neutrophil granule cationic protein shares homology with inflammatory proteinases. Life Sci 46(3):189\u2013196","journal-title":"Life Sci"},{"issue":"10","key":"1347_CR36","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1073\/pnas.90.10.4733","volume":"90","author":"HA Pereira","year":"1993","unstructured":"Pereira HA, Erdem I, Pohl J, Spitznagel JK (1993) Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci USA 90(10):4733\u20134737","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1347_CR37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0197-4580(96)00118-2","volume":"17","author":"HA Pereira","year":"1996","unstructured":"Pereira HA, Kumar P, Grammas P (1996a) Expression of CAP37, a novel inflammatory mediator, in Alzheimer\u2019s disease. Neurobiol Aging 17(5):753\u2013759","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1347_CR38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jlb.60.3.415","volume":"60","author":"HA Pereira","year":"1996","unstructured":"Pereira HA, Moore P, Grammas P (1996b) CAP37, a neutrophil granule-derived protein stimulates protein kinase C activity in endothelial cells. J Leukoc Biol 60(3):415\u2013422","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1347_CR39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/glia.10167","volume":"41","author":"HA Pereira","year":"2003","unstructured":"Pereira HA, Ruan X, Kumar P (2003) Activation of microglia: a neuroinflammatory role for CAP37. Glia 41(1):64\u201372","journal-title":"Glia"},{"issue":"12","key":"1347_CR40","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1167\/iovs.03-1052","volume":"45","author":"HA Pereira","year":"2004","unstructured":"Pereira HA, Ruan X, Gonzalez ML, Tsyshevskaya-Hoover I, Chodosh J (2004) Modulation of corneal epithelial cell functions by the neutrophil-derived inflammatory mediator CAP37. Invest Ophthalmol Vis Sci 45(12):4284\u20134292","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1347_CR41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6(4):193\u2013201","journal-title":"Nat Rev Neurol"},{"key":"1347_CR42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphar.2014.00097","volume":"5","author":"R Piacentini","year":"2014","unstructured":"Piacentini R, De Chiara G, Li Puma DD, Ripoli C, Marcocci ME, Garaci E, Palamara AT, Grassi C (2014) HSV-1 and Alzheimer\u2019s disease: more than a hypothesis. Front Pharmacol 5:97","journal-title":"Front Pharmacol"},{"issue":"5","key":"1347_CR43","first-page":"1414","volume":"43","author":"X Ruan","year":"2002","unstructured":"Ruan X, Chodosh J, Callegan MC, Booth MC, Lee TD, Kumar P, Gilmore MS, Pereira HA (2002) Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci 43(5):1414\u20131421","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1347_CR44","doi-asserted-by":"crossref","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido T, Leissring MA (2012) Proteolytic degradation of amyloid beta-protein. Cold Spring Harb Perspect Med 2(6):a006379","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"1347_CR45","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.052587399","volume":"99","author":"RI Scahill","year":"2002","unstructured":"Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer\u2019s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99(7):4703\u20134707","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1347_CR46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.24052","volume":"75","author":"CS Scherling","year":"2014","unstructured":"Scherling CS, Hall T, Berisha F, Klepac K, Karydas A, Coppola G, Kramer JH, Rabinovici G, Ahlijanian M, Miller BL, Seeley W, Grinberg LT, Rosen H, Meredith J Jr, Boxer AL (2014) Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol 75(1):116\u2013126","journal-title":"Ann Neurol"},{"issue":"1","key":"1347_CR47","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"1347_CR48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1167\/iovs.07-0405","volume":"49","author":"D Skondra","year":"2008","unstructured":"Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam A (2008) Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci 49(2):726\u2013731","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1347_CR49","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","volume":"5","author":"SJ Soscia","year":"2010","unstructured":"Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5(3):e9505","journal-title":"PLoS One"},{"issue":"3","key":"1347_CR50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000071001","volume":"16","author":"YX Sun","year":"2003","unstructured":"Sun YX, Minthon L, Wallmark A, Warkentin S, Blennow K, Janciauskiene S (2003) Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 16(3):136\u2013144","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"1347_CR51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-2008-13407","volume":"13","author":"N Urosevic","year":"2008","unstructured":"Urosevic N, Martins RN (2008) Infection and Alzheimer\u2019s disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 13(4):421\u2013435","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1347_CR52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/fmb.12.1","volume":"7","author":"NM Sorge van","year":"2012","unstructured":"van Sorge NM, Doran KS (2012) Defense at the border: the blood-brain barrier versus bacterial foreigners. Future Microbiol 7(3):383\u2013394","journal-title":"Future Microbiol"},{"issue":"1","key":"1347_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jalz.2013.12.020","volume":"11","author":"MM Welling","year":"2015","unstructured":"Welling MM, Nabuurs RJ, van der Weerd L (2015) Potential role of antimicrobial peptides in the early onset of Alzheimer\u2019s disease. Alzheimers Dement 11(1):51\u201357","journal-title":"Alzheimers Dement"},{"issue":"7","key":"1347_CR54","doi-asserted-by":"crossref","first-page":"e101364","DOI":"10.1371\/journal.pone.0101364","volume":"9","author":"MR White","year":"2014","unstructured":"White MR, Kandel R, Tripathi S, Condon D, Qi L, Taubenberger J, Hartshorn KL (2014) Alzheimer\u2019s associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One 9(7):e101364","journal-title":"PLoS One"},{"key":"1347_CR55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-10-127","volume":"10","author":"WM Williams","year":"2013","unstructured":"Williams WM, Torres S, Siedlak SL, Castellani RJ, Perry G, Smith MA, Zhu X (2013) Antimicrobial peptide beta-defensin-1 expression is upregulated in Alzheimer\u2019s brain. J Neuroinflammation 10:127","journal-title":"J Neuroinflammation"},{"issue":"12","key":"1347_CR56","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1532-5415.2002.50619.x","volume":"50","author":"CJ Wilson","year":"2002","unstructured":"Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition\u2013the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50(12):2041\u20132056","journal-title":"J Am Geriatr Soc"}],"container-title":["Histochemistry and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00418-015-1347-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-015-1347-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-015-1347-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T01:28:38Z","timestamp":1566955718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00418-015-1347-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1007\/s00418-015-1347-x","relation":{},"ISSN":["0948-6143","1432-119X"],"issn-type":[{"value":"0948-6143","type":"print"},{"value":"1432-119X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}